SCHEDULE 13G/A
Statement of Beneficial Ownership
Kura Oncology, Inc. Filed Acc 0000921895-26-003183
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BVF PARTNERS L P/IL | 6,690,108 | 7.5% |
| BVF INC/IL | 6,690,108 | 7.5% |
| LAMPERT MARK N | 6,690,108 | 7.5% |
| BVF GP HOLDINGS LLC | 6,120,843 | 6.9% |
| BIOTECHNOLOGY VALUE FUND L P | 3,499,795 | 3.9% |
| BVF I GP LLC | 3,499,795 | 3.9% |
| BIOTECHNOLOGY VALUE FUND II LP | 2,621,048 | 2.9% |
| BVF II GP LLC | 2,621,048 | 2.9% |
| Biotechnology Value Trading Fund OS LP | 443,395 | 0.5% |
| BVF Partners OS Ltd. | 443,395 | 0.5% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…